PT KALBE FARMA TBK.
Jakarta, January 16, 2021 - PT Kalbe Farma Tbk (Kalbe) through the One Onco division along with the Indonesian Cancer Care Community (ICCC) and the Indonesian Cancer Foundation (YKI) of West Java, and is also supported by KALGen INNOLAB; conducted an online education event to commemorate the Cervical Cancer Awareness Month 2021 through a webinar themed 'Time for Cervical Cancer Screening' with speaker dr. Gatot N.A. Winarno, Sp.OG(K), M.Kes. This education event aims to increase public awareness of the importance of screening efforts for cervical cancer, given that the current incidence of and deaths from cervical cancer in Indonesia is still the second-highest after breast cancer.
'Kalbe routinely provides education events on health issues for the community, one of which is the importance of cervical cancer screening,' said dr. Selvinna, Marketing General Manager of One Onco of PT Kalbe Farma Tbk. 'The education event is conducted to raise awareness of the early prevention of cervical cancer for Indonesian women, as well as to commemorate the Cervical Cancer Awareness Month,' added dr. Selvinna.
'Cervical cancer is a disease that can be prevented with early detection of HPV (Human Papilloma Virus) DNA routinely, especially for women who already had sexual intercourse,' said dr. Gatot N.A. Winarno, Sp.OG(K), M.Kes. 'To the present day, cervical cancer has the second-highest mortality case after breast cancer in women because of the lack of early screening. Early detection methods of cervical cancer that exist today include IVA (visual Inspection of acetic acid), pap smear, Liquid-Based pap smear, and HPV DNA. The HPV DNA test was done to detect the occurrence of the high-risk HPV infection that can cause cervical cancer early. The sooner cervical cancer is detected, it can be more easily treated,' added dr. Gatot.
'During the Cervical Cancer Awareness Month, Kalbe holds an HPV DNA Screening Program in collaboration with YKI of West Java and competent Healthcare Workers. The HPV DNa includes tests on 15 high risk subtypes. The test is supported by Kalgen Innolab Laboratory belonging to the Kalbe Group, that provides laboratory services starting from simple tests to the more sophisticated ones such as molecular tests to support a more precise treatment,' concluded dr. Selvinna.
One Onco is an integrated oncology service (ecosystem), that provides a comprehensive solution for cancer patients, through integrated diagnostic service, therapy (medication), to the community. It is hoped that the holistic service will be able to help increase the quality of life of cancer patients and their families.
Cervical Cancer Awareness Month takes place in January 2021, with activities that aim to increase public awareness of the importance of cervical cancer screening as well as increasing the coverage of cervical cancer screening in Indonesia.
Indonesia Cancer Care Community (ICCC) at a glance
Indonesia Cancer Care Community (ICCC) is a community that was established on February 27, 2010. Founded by cancer patients, survivors, and cancer observers. ICCC has routine activities such as cancer-related health seminars, visiting cancer patients at cancer clinics in a number of hospitals, and excursions that are conducted every year. In some of its activities, ICCC is supported by KECC in the capacity as a facilitator, specifically in organizing cancer seminars.
Kalbe at a glance
PT Kalbe Farma Tbk ('Kalbe') was established in 1966 and is one of the largest listed pharmaceutical companies in Southeast Asia. Kalbe has four main divisions that handle reliable and varied brand portfolio: prescription medicines (Cefspan, Brainact, Broadced, etc.); health product division that handles over-the-counter medication (Promag, Mixagrip, Komix, Woods, Fatigon, etc.); multivitamins (Fatigon, H2, XonCe, Hevit-C, JossC1000, etc.); as well as supplement and ready-to-consume drinks (Hydro Coco, Extra Joss); nutrition division (ChilKid, Prenagen, Diabetasol, Zee, etc,); and distribution division. Kalbe currently has approximately 40 subsidiaries and 14 production facilities with international standard and employs approximately 17,000 employees dispersed across more than 76 branches throughout Indonesia. Since 1991, Kalbe is listed on the Indonesia Stock Exchange (IDX: KLBF).
--oOo--
Attachments
- Original document
- Permalink
Disclaimer
PT Kalbe Farma Tbk published this content on 16 January 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 January 2021 11:05:03 UTC
